摘 要 青光眼是一组具有不可逆性和致盲性的神经退行性疾病，其主要临床表现为特异性的视神经萎缩和视野缺损，治疗目标为阻止视神经的进一步损害。随着人口老龄化加剧，全球青光眼患者数逐年增加，预计到2040年将增至1.118亿人。青光眼微创手术具有损伤轻、并发症少、效果佳等优势。本文概要介绍近年来国内外青光眼微创手术的研究进展。

    关键词 青光眼 眼压 微创手术

    中图分类号：R775 文献标志码：A 文章编号：1006-1533(2024)21-0007-06

    引用本文 黄帅， 沙倩. 青光眼微创手术的研究进展[J]. 上海医药， 2024， 45(21)： 7-12.

    Research progress of minimally invasive glaucoma surgery

    HUANG Shuai， SHA Qian

    (Department of Ophthalmology， Shanghai Pudong Hospital， Shanghai 201399， China)

    ABSTRACT As a group of neurodegenerative disease with irreversibility and blindness， glaucoma is primarily evidenced by the deterioration of optic nerves and visual field impairments. With the continuous development of the aging population， the number of annual glaucoma patients in the world is increasing year by year and is expected to increase to 111.8 million by 2040. Minimally invasive glaucoma surgery (MIGS) has the advantages of light damage， few complications and good results. This article reviews the research progress in MIGS at home and abroad in recent years.

    KEY WORDS glaucoma； intraocular pressure； minimally invasive surgery ......